Yuflyma®
-
- Product Name : Yuflyma®
- INN : adalimumab
- Indications : Rheumatoid arthritis, Axial spondyloarthritis, Psoriasis, Psoriatic arthritis, Crohn’s disease, Hidradenitis suppurativa, Ulcerative colitis, Uveitis, Paediatric plaque psoriasis, paediatric Crohn’s disease, paediatric ulcerative colitis, paediatric uveit
- Protein Type : Monoclonal antibody (mAb)
- Mechanism of Action : Specifically targets and blocks TNF-alpha which contributes to the inflammation.
- Drug Approval Status : EU (2021-02-11)
This product description is for medical and educational purposes only.
They are not intended to promote PR or sales campaigns.
For more details, please consult a doctor or a medical specialist. This site is intended for all over the world.
